The rapid adoption of GLP-1 weight loss medications — drugs like Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Zepbound and Mounjaro — is reshaping how Americans eat and shop.

It’s also changing how major corporations do business.

From new product lines to expanding certain categories, companies are trying to capitalize on the lifestyle shifts prompted by the popular drugs.

“We’re like at the tip of the iceberg in terms of what I think this is going to mean for how it changes consumer behavior,” Lisa Roath, Target’s chief merchandising officer of food, essentials and beauty, told FOX Business.

Target has been tracking emerging trends to help drive its product purchasing decisions as it contends with subdued traffic and stiff competition.

Target buyers are expected to stay plugge

See Full Page